• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23368 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Screening for depression]
2018     National Institute for Health and Care Excellence (NICE) Sutureless aortic valve replacement for aortic stenosis. NICE interventional procedures guidance 624
2018     Adelaide Health Technology Assessment (AHTA) Extended half-life clotting factor concentrates for the treatment of haemophilia A and B
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Biofeedback in adults with fecal and/or urinary incontinence]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for a national health portal]
2018     National Institute for Health and Care Excellence (NICE) Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia. NICE interventional procedures guidance 625
2018     Medical Services Advisory Committee (MSAC) Computed tomography coronary angiogram - multi-slice computed tomography coronary angiography in the visualisation of coronary arteries
2018     NIHR Health Technology Assessment programme Interventions to improve antimicrobial prescribing of doctors in training (IMPACT): a realist review
2018     Adelaide Health Technology Assessment (AHTA) Heritable mutations which increase risk in colorectal and endometrial cancer
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Vertebroplasty or kyphoplasty in osteoporotic vertebral fractures]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Biomarker-based tests for the decision for or against adjuvant systemic chemotherapy in primary breast cancer - Addendum to Commission D14-01]
2018     National Institute for Health and Care Excellence (NICE) Low-intensity pulsed ultrasound to promote healing of fresh fractures at low risk of non-healing. NICE interventional procedures guidance 621
2018     Adelaide Health Technology Assessment (AHTA) Anti-Mullerian Hormone (AMH) testing for female patients who will or have received gonadotoxic treatment
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Trabecular micro bypass stent for glaucoma]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Hydrocortisone (adrenal insufficiency) - Benefit assessment according to §35a Social Code Book V]
2018     National Institute for Health and Care Excellence (NICE) Low-intensity pulsed ultrasound to promote healing of fresh fractures at high risk of non-healing. NICE interventional procedures guidance 622
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Osimertinib (Tagrisso®) for the initial treatment of EGFR-mutated advanced non–small-cell lung cancer (NSCLC)
2018     Norwegian Institute of Public Health (NIPH) EXOGEN™ in the treatment of non-union fractures. A single technology assessment
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Lumacaftor/Ivacaftor therapy in cystic fibrosis]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ertugliflozin/sitagliptin (type 2 diabetes mellitus) - Benefit assessment according to §35a Social Code Book V]
2018     National Institute for Health and Care Excellence (NICE) Low-intensity pulsed ultrasound to promote healing of delayed-union and non-union fractures. NICE interventional procedures guidance 623
2018     Norwegian Institute of Public Health (NIPH) Effectiveness and safety of nitrous oxide as sedation regimen in children – an HTA
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Cognitive rehabilitation in secondary cognitive impairment]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Rurioctocog alfa pegol (haemophilia A) - Benefit assessment according to §35a Social Code Book V]
2018     National Institute for Health and Care Excellence (NICE) Superior capsular augmentation for massive rotator cuff tears. NICE interventional procedures guidance 619
2018     Norwegian Institute of Public Health (NIPH) Autologous hematopoietic stem cell transplantation (AHSCT) for Diffuse Systemic Sclerosis. Health Technology Assessment
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: cardiopulmonary resuscitation (CPR) in a context of community-based naloxone administration for opioid overdose]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Scalp cooling in patients at risk of chemotherapy-induced alopecia]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Darvadstrocel (perianal fistulas in Crohn disease) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2018     National Institute for Health and Care Excellence (NICE) Transaxial interbody lumbosacral fusion for severe chronic low back pain. NICE interventional procedures guidance 620
2018     Norwegian Institute of Public Health (NIPH) The MicraTM Transcatheter Pacing System, a leadless pacemaker, in patients indicated for single-chamber ventricular pacemaker implantation: A single technology assessment
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Negative-pressure wound therapy for chronic wounds]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Bosutinib (chronic myeloid leukaemia) - Benefit assessment according to §35a Social Code Book V]
2018     National Institute for Health and Care Excellence (NICE) Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor. NICE interventional procedures guidance 617
2018     NIHR Health Technology Assessment programme A staff training intervention to improve communication between people living with dementia and health-care professionals in hospital: the VOICE mixed-methods development and evaluation study
2018     Norwegian Institute of Public Health (NIPH) 177Lutetium-based peptide receptor radionuclide therapy for treating neuroendocrine tumours: a health technology assessment
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Vitamin D - population screening and supplementation in populations with deficit]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Emicizumab (haemophilia A) - Addendum to Commission A18-20]
2018     National Institute for Health and Care Excellence (NICE) Laparoscopic ventral mesh rectopexy for internal rectal prolapse. NICE interventional procedures guidance 618
2018     Norwegian Institute of Public Health (NIPH) Diagnostic accuracy, clinical effectiveness and budget impact of screening BRCA1/2 mutation carriers by MRI. A health technology assessment
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Negative-pressure wound therapy]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cariprazine (schizophrenia) - Addendum to Commission A18-25]
2018     National Institute for Health and Care Excellence (NICE) Intranasal phototherapy for allergic rhinitis. NICE interventional procedures guidance 616
2018     NIHR Health Technology Assessment programme Nurse staffing levels, missed vital signs and mortality in hospitals: retrospective longitudinal observational study.
2018     Norwegian Institute of Public Health (NIPH) Bariatric surgery for Type 2 Diabetes and a body mass index below 35
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Positron emission tomography (pet) for routine follow-up of selected neoplasms]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dolutegravir/rilpivirine (HIV infection) - Benefit assessment according to §35a Social Code Book V]
2018     National Institute for Health and Care Excellence (NICE) Golimumab for treating non-radiographic axial spondyloarthritis. NICE technology appraisal guidance 497
2018     National Institute for Health and Care Excellence (NICE) Endoscopic bipolar radiofrequency ablation for treating biliary obstruction caused by cancer. NICE interventional procedures guidance 614
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: a profile of the practices adopted in Quebec to facilitate the transition to adulthood of young people who reside in an alternative living facility]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Rituximab for patients with diagnosed chronic neuromyelitis, myasthenia gravis and chronic inflammatory demyelinating polyneuropathy]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cabozantinib (renal cell carcinoma) - Benefit assessment according to §35a Social Code Book V]
2018     National Institute for Health and Care Excellence (NICE) Lenvatinib with everolimus for previously treated advanced renal cell carcinoma. NICE technology appraisal guidance 498
2018     National Institute for Health and Care Excellence (NICE) Low-level laser therapy for preventing or treating oral mucositis caused by radiotherapy or chemotherapy. NICE interventional procedures guidance 615
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Flash glucose monitoring system in diabetes mellitus patients]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nivolumab (melanoma) - Benefit assessment according to §35a Social Code Book V (expiry of the decision)]
2018     National Institute for Health and Care Excellence (NICE) Glecaprevir–pibrentasvir for treating chronic hepatitis C. NICE technology appraisal guidance 499
2018     National Institute for Health and Care Excellence (NICE) Percutaneous balloon valvuloplasty for fetal critical aortic stenosis. NICE interventional procedures guidance 613
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: strategies to optimize the appropriateness of MRI and CT requests - strategies and tools for optimal use]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Ceftazidime/avibactam in severe infections]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Olaparib (ovarian, fallopian tube, peritoneal cancer) - Benefit assessment according to §35a Social Code Book V]
2018     National Institute for Health and Care Excellence (NICE) Ceritinib for untreated ALK-positive non-small-cell lung cancer. NICE technology appraisal guidance 500
2018     National Institute for Health and Care Excellence (NICE) Robot-assisted kidney transplant. NICE interventional procedures guidance 609
2018     Swiss Federal Office of Public Health (FOPH) Knee arthroscopy for the treatment of degenerative changes
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: surgical treatment of the esophagus - quality and accessibility in Quebec]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [FilmArray® in Acute Respiratory Infections and Sepsis]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Screening for hepatitis B]
2018     National Institute for Health and Care Excellence (NICE) Intrabeam radiotherapy system for adjuvant treatment of early breast cancer. NICE technology appraisal guidance 501
2018     National Institute for Health and Care Excellence (NICE) Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia. NICE interventional procedures guidance 611
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: mild traumatic brain injury, knowledge update in preparation for the revision of the ministerial orientations for mild traumatic brain injury (2005-2010)]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Screening for hepatitis C]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Amyloid PET in dementia of unclear aetiology]
2018     National Institute for Health and Care Excellence (NICE) Ibrutinib for treating relapsed or refractory mantle cell lymphoma. NICE technology appraisal guidance 502
2018     National Institute for Health and Care Excellence (NICE) Microinvasive subconjunctival insertion of a trans-scleral gelatin stent for primary open-angle glaucoma. NICE interventional procedures guidance 612
2018     NIHR Health Technology Assessment programme Systematic review of treatment of dry age-related macular degeneration and Stargardt's disease
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice in pediatric trauma care: patients admitted to the designated facilities of the trauma care network between 2010 and 2015]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Implantable cardiac defibrillator for primary prevention of sudden death]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pertuzumab (breast cancer) - Benefit assessment according to §35a Social Code Book V]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Amyloid PET in dementia of unclear aetiology (Addendum to Commission E18-03)]
2018     National Institute for Health and Care Excellence (NICE) Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer. NICE technology appraisal guidance 503
2018     National Institute for Health and Care Excellence (NICE) Nerve transfer to partially restore upper limb function in tetraplegia. NICE interventional procedures guidance 610
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Daratumumab (Darzalex®) in combination with bortezomib, melphalan and prednisone for untreated myeloma
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Transcatheter aortic valve implantation for severe aortic stenosis]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Bictegravir/emtricitabine/tenofovir alafenamide (HIV infection) - Benefit assessment according to §35a Social Code Book V]
2018     National Institute for Health and Care Excellence (NICE) Pirfenidone for treating idiopathic pulmonary fibrosis. NICE technology appraisal guidance 504
2018     National Institute for Health and Care Excellence (NICE) Mosaicplasty for symptomatic articular cartilage defects of the knee. NICE interventional procedures guidance 607
2018     NIHR Health Technology Assessment programme Screening women aged 65 years or over for abdominal aortic aneurysm: a modelling study and health economic evaluation
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Re-orientation of the Austrian parent-child preventive care programme. Part XI: Further development of the mother-child-pass: Screening recommendations of the expert working group for pregnancy, puerperium and early childhood (0-6 years)
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Aortic valve replacement with rapid deployment or sutureless valves]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ipilimumab (melanoma) - Benefit assessment according to §35a Social Code Book V]
2018     National Institute for Health and Care Excellence (NICE) Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C. NICE technology appraisal guidance 507
2018     National Institute for Health and Care Excellence (NICE) Laparoscopic mesh pectopexy for apical prolapse of the uterus or vagina. NICE interventional procedures guidance 608
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Stereotactic radiotherapy, proton therapy and irreversible electroporation for the treatment of localised prostate cancer
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Dipeptidyl peptidase-4 (dpp4) inhibitors in diabetes mellitus]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Velmanase alfa (enzyme replacement treatment for mild to moderate alpha-mannosidosis) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2018     National Institute for Health and Care Excellence (NICE) Autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the knee. NICE technology appraisal guidance 508
2018     National Institute for Health and Care Excellence (NICE) Unilateral MRI-guided focused ultrasound thalamotomy for moderate to severe tremor in Parkinson's disease. NICE interventional procedures guidance 606
2018     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Patient Health Questionnaire- 9, PHQ-9, for depression screening in adults]
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Endobronchial valve implantation for emphysema. Update 2018
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Single-use negative pressure wound therapy for acute and chronic wounds]